Conditioned Place Preference as a Preclinical Model for Screening Pharmacotherapies for Drug Abuse

Michael T. Bardo, David B. Horton, Justin R. Yates

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

7 Scopus citations


Conditioned place preference (CPP) is established by pairing a context conditioned stimulus with an abused drug. With repeated context-drug pairings, the context alone acquires positive incentive value that elicits approach behavior. While CPP can be and is frequently applied to identify the reinforcing effects of drugs, this chapter will instead cover different applications: (1) efficacy studies in developing novel pharmacotherapies for drug abuse and (2) preclinical safety assessment of the abuse liability of novel drugs in the development of medications. Depending on when a potential pharmacotherapeutic is administered, either acquisition or expression of drug CPP can be blocked. In addition, following a period of extinction to the context, a pharmacotherapeutic may block reinstatement of drug seeking. Some results obtained with stimulant-, opioid-, and ethanol-induced reward are covered to illustrate the versatility of CPP for identifying novel targets for medication development.

Original languageEnglish
Title of host publicationNonclinical Assessment of Abuse Potential for New Pharmaceuticals
Number of pages46
ISBN (Electronic)9780124202160
StatePublished - Aug 7 2015

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved..


  • Conditioned place preference
  • Drug abuse
  • Drug reward
  • Medication development
  • Pharmacotherapy

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • General Medicine


Dive into the research topics of 'Conditioned Place Preference as a Preclinical Model for Screening Pharmacotherapies for Drug Abuse'. Together they form a unique fingerprint.

Cite this